Claudio Pusceddu

Papers

1

Total Citations

4

H-Index

1

About

Claudio Pusceddu is a leading figure in interventional oncology and minimally invasive renal surgery, with a particular focus on advancing nephron-sparing techniques. His most cited work introduces a groundbreaking "green tattoo" pre-operative renal embolization method, combining indocyanine green with the non-adhesive liquid embolic agent Onyx-18 for robotic-assisted and laparoscopic partial nephrectomy. This innovation, detailed in a 2022 study involving 13 patients, enables real-time near-infrared fluorescence imaging to precisely demarcate tumor margins and reduce intraoperative bleeding. By integrating embolization with fluorescence-guided surgery, Pusceddu has enhanced surgical precision and safety, directly addressing challenges in complex partial nephrectomies. His contributions have garnered attention in the urological and interventional radiology communities, with his seminal paper accumulating 4 citations—a notable impact for a recent technique. Pusceddu’s work bridges interventional radiology and surgical oncology, offering a practical, reproducible approach that may expand the eligibility for minimally invasive renal preservation. His research continues to influence clinical protocols, emphasizing patient-centered outcomes and technological integration in cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Green Tattoo Pre-Operative Renal Embolization for Robotic-Assisted and Laparoscopic Partial Nephrectomy: A Practical Proof of a New Technique
4 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 12

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago